| 1.01 0.02 (2%) | 08-08 00:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care centers across the United States, which it either owns, manages, or subleases. These outpatient clinics specialize in delivering innovative regenerative, orthopedic, and minimally invasive therapies. Their services are designed to address a range of conditions, including athletic injuries, damage to ligaments and tendons, other soft tissue ailments, and chronic back, knee, and joint pain. Additionally, the company offers physical therapy, spinal decompression, and chiropractic manipulation. Established in 2000 and based in Brentwood, Tennessee, IMAC Holdings, Inc. currently oversees or possesses 15 such outpatient medical facilities located in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida.
Sat, 01 Aug 2026
IMAC Holdings, Inc. Revenue Breakdown – OTC:BACK - TradingView
Thu, 11 Jun 2026
M5 iMac – is it REALLY a possibility? - talkingtechandaudio.com
Tue, 25 Mar 2025
IMAC Holdings delisted from the Nasdaq, looking to listing elsewhere - The Business Journals
Mon, 27 Jan 2025
IMAC Holdings Launches Ignite Proteomics to Revolutionize Cancer Treatment Selection with Protein-Level Insights - Quiver Quantitative
Fri, 23 Aug 2024
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewswire
Mon, 15 Jul 2024
IMAC Holdings did 3 things to avoid Nasdaq delisting - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |